Skip to main content

Table 3 Differences between patients SCORE < 5% vs. mSCORE 5%, (n = 888)

From: Participation in cardiovascular screening consultations, the who, when and why - A cohort study on patients with rheumatoid arthritis

Variables

Crude OR

Multivariate analysis

Adjusted OR

(CI 95%)a

p-value

(CI 95%)a

p-value

Disease duration, years

1.017 (1.002–1.032)

0.019

1.028 (1.008–1.048)

0.005

Triglycerides

1.834 (1.475–2.280)

 < 0.001

1.457 (1.126–1.886)

0.004

HbAlc

1.046 (1.020–1.070)

 < 0.001

1.033 (0.999–1.066)

0.055

Unhealthy lifestyle factors

 Alcohol above national limits

Women ≥ 7

1.242 (0.732–2.107)

0.421

Men ≥ 14

0.838 (0.408–1.718)

0.630

 Physical activity

0–2 days per month

1

Ref

1

Ref

1–4 days per week

0.758 (0.555–1.036)

0.083

0.909 (0.605–1.366)

0.647

5 or more days per week

0.859 (0.614–1.201)

0.375

1.020 (0.654–1.591)

0.928

 High waist circumference

Women ≥ 80 cm

0.712 (0.432–1.174)

0.183

0.585 (0.322–1.064)

0.079

Men ≥ 94 cm

1.451 (0.829–2.540)

0.192

1.001 (0.509–1.971)

0.996

Measure of disease impact

 Pain

1.006 (1.001–1.012)

0.022

1.027 (1.011–1.045)

0.001

 Fatigue

1.000 (0.995–1.005)

0.884

0.994 (0.982–1.001)

0.321

 PatGA

1.001 (0.996–1.061)

0.575

0.978 (0.962–0.996)

0.014

 HAQ

1.305 (1.057–1.612)

0.013

1.33 (0.91–1.96)

0.137

 EQ-5D-5L

0.39 (0.311–0.531)

0.531

0.722 (0.195–2.669)

0.640

  1. aLogistic regression analyses
  2. Data presented as odds ratio (OR) and 95% confidence intervals
  3. Pain (0–100, best to worst); Fatigue (0–100, best to worst)
  4. PatGa patient global assessment (0–100, best to worst); pain (0–100, best to worst), HAQ Health Assessment Questionnaire (0–3, best to worst), EQ-5D-5L Five level Euroqol Five Dimensions (0–1, worst to best)
  5. Statistically significant p-values are in bold